A Safety and Tolerability Study of Mexiletine in Patients With Sporadic Amyotrophic Lateral Sclerosis (SALS)
Phase of Trial: Phase II
Latest Information Update: 24 Feb 2016
At a glance
- Drugs Mexiletine (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions
- 24 Feb 2016 Results published in the Neurology
- 25 Apr 2015 Results presented at the 67th Annual Meeting of the American Academy of Neurology.
- 25 Apr 2015 Status changed from active, no longer recruiting to completed according to results presented at the 67th Annual Meeting of the American Academy of Neurology.